Gaxos Acquires Rights to AI-enabled Technology from Top Biohacking App
13 Marzo 2024 - 1:30PM
Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing
artificial intelligence applications across various sectors, today
announced that it had acquired the rights to use certain AI-enabled
technology from a top biohacking app, “Ultiself,” in order to
facilitate the development of its tech for Gaxos Health.
The integration of Ultiself’s proprietary
technology into Gaxos Health’s proposed product offering will
enable enhanced customization and user experience aligning with
modern-day consumer’s demands for custom and efficient solutions.
This move is expected to accelerate Gaxos Health’s development and
help solidify its position in the health and wellness industry.
“By securing the rights to use this tech,
we will be able to accelerate the development of our AI-enabled
application for the Gaxos Health product offering,” said Vadim
Mats, CEO of Gaxos.AI. “This tech is intended to allow us to offer
a more customized approach to delivering customers diet, nutrition,
and tracking capabilities.
The integration process will commence
immediately, with both teams working closely to ensure a smooth
transition. Gaxos is committed to leveraging this new technology to
provide value to its customers and stakeholders.
About Gaxos.ai Inc.
Gaxos.AI isn't just developing applications; its
aim is to redefine the human-AI relationship. Our offerings are
being expanded to include health and wellness, as well as gaming.
We're committed to addressing health, longevity, and entertainment
through AI solutions.
Forward-Looking Statements
All statements other than statements of
historical fact in this announcement are forward-looking statements
that involve known and unknown risks and uncertainties and are
based on current expectations and projections about future events
and financial trends that the Company believes may affect its
financial condition, results of operations, business strategy, and
financial needs. Investors can identify these forward-looking
statements by words or phrases such as “may,” “will,” “expect,”
“anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,”
“potential,” “continue,” “is/are likely to” or other similar
expressions. The Company undertakes no obligation to update
forward-looking statements to reflect subsequent occurring events
or circumstances, or changes in its expectations, except as may be
required by law. Although the Company believes that the
expectations expressed in these forward-looking statements are
reasonable, it cannot assure you that such expectations will turn
out to be correct, and the Company cautions investors that actual
results may differ materially from the anticipated results and
encourages investors to review other factors that may affect its
future results in the Company’s filings with the SEC.
Gaxos.ai Inc. Company
Contact
Investor RelationsE:ir@gaxos.aiT: 1-888-319-2499
Grafico Azioni Gaxos ai (NASDAQ:GXAI)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Gaxos ai (NASDAQ:GXAI)
Storico
Da Nov 2023 a Nov 2024